Filter
700
Text search:
controlled
substances
Featured
Recommendations
92
New Publications
142
Language
Document type
No document type
376
Guidelines
149
Studies & Reports
80
Manuals
57
Strategic & Response Plan
18
Training Material
15
Fact sheets
4
Situation Updates
1
Countries / Regions
India
30
Kenya
29
Global
24
South Africa
22
Western and Central Europe
19
Nigeria
16
Uganda
15
Ghana
12
Ethiopia
11
Nepal
10
Sierra Leone
9
Tanzania
8
Liberia
7
Indonesia
7
Myanmar / Burma
7
Zimbabwe
6
Rwanda
6
Namibia
6
Eswatini/ Swaziland
6
Africa
6
Zambia
5
Ukraine
5
Eastern Europe
5
Russia
5
Syria
4
Malawi
4
Botswana
4
Lesotho
4
Guinea
3
Senegal
3
USA
3
Philippines
3
Afghanistan
3
Germany
3
Bangladesh
3
South–East Asia Region
3
Latin America and the Carribbean
3
Burkina Faso
2
Congo, Democratic Republic of
2
South Sudan
2
Iraq
2
Lebanon
2
Cambodia
2
Thailand
2
Argentina
2
North Macedonia
2
Hungary
2
Yemen
2
Eastern Europe and Central Asia
2
Tajikistan
2
Kyrgyzstan
2
Mali
1
Morocco
1
Cameroon
1
Pakistan
1
Jordan
1
Mozambique
1
Papua New Guinea
1
Sudan
1
Brazil
1
Serbia
1
Colombia
1
Mexico
1
West and Central Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Asia
1
Venezuela
1
Poland
1
Albania
1
Moldova
1
Iran
1
Australia
1
Kazakhstan
1
Georgia
1
Jamaica
1
France
1
United Kingdom
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
224
Clinical Guidelines
54
Key Resources
34
Public Health
26
Pharmacy & Technologies
23
Women & Child Health
21
Capacity Building
9
Toolboxes
Mental Health
138
Pharmacy
61
HIV
35
Caregiver
29
AMR
27
COVID-19
26
TB
25
Planetary Health
21
Ebola & Marburg
19
NCDs
19
Rapid Response
18
Specific Hazards
14
NTDs
11
Conflict
10
2.0 Rapid Response
9
Global Health Education
7
Malaria
7
Natural Hazards
5
Refugee
5
Cholera
3
Disability
2
Polio
2
Social Ethics
2
Last revised 2015.
Original Word document on: http://www.epnetwork.org/Resources/Standard%20Operating%20Procedure/Controlled%20substances%20dispensing%20record_Form.doc
Millennium Development Goal 8E aims for affordable access to essential medicines. Essential medicines, as defined by WHO, are those that “satisfy the health-care needs of the majority of the population” and that should therefore “be available at all times in adequate amounts”. However, there
...
Instruction of the President of the Republic of Indonesia No. 3 of 2002 concerning the Control of Illicit Abuse and Distribution of Narcotics, Psychotropic, Precursors and other Addictive Substances
The availability of controlled medicines is crucial for patients requiring palliative care, pain relief and symptom management. Many individuals worldwide, especially in low- and middle-income countries, continue to experience limited access to thes
...
GOVERNMENT NOTICE | No. 192 Promulgation of Medicines and Related Substances Control Act, 2003 (Act No. 13 of 2003), of the Parliament
Medicines and Allied Substances [No. 3 of 2013 47 | An Act to continue the existence of the Pharmaceutical Regulatory Authority and re-name it as the Zambia Medicines Regulatory Authority; provide for the functions and powers of the Authority; provi
...
Statutory Instrument 150 of 1991 | S.I. 150 of 1991 | Amended by S.I.’ s 298/93, 61/94, 319/94, 199/98, 256/98, 36/99, 24/2001 and 257/2002, 105 and 222 /2004
These guidelines have been developed in simple, user-friendly language and they explain the procedures for patients’ access to and the safe management of Schedule I and II drugs that are necessary for the treatment and relief of moderate to severe pain. They provide both procedures for acquisition
...
WHO guideline on balanced national controlled medicines policies to ensure medical access and safety
Access to medicines is essential for attainment of universal health coverage, which is central to achievement of the health-related Sustainable Development Goals. Controlled medicines include those such as opioids, benzodiazepines, barbiturates, amp
...
This publication provides information for identifying, classifying, marking, labelling, packaging, documenting and refrigerating infectious substances for transportation and ensuring their safe delivery.
The document provides practical guidance to
...
Constituting the fourth part of the World Drug Report 2022, this booklet focuses on the market dynamics of various stimulants – cocaine, amphetamines and “ecstasy” – and of NPS.
The first chapter contains an analysis of the global market for cocaine, starting with a review of cocaine supply
...
Access to controlled medicines. 3rd edition
The Access to Controlled Medications Programme identified the development of treatment guidelines that cover the treatment of all types of pain as one of the core areas of focus for improving access to opioid analgesics. Such guidelines are interes
...
Amphetamine-type stimulants, new psychoactive substances
-4-
World Drug Report 2017
Accessed: 14.03.2019
This user guide is designed to provide national malaria control programmes with general information on glucose-6-phosphate dehydrogenase (G6PD) deficiency. Individuals with this condition may be at risk of adverse effects from medicines commonly used to cure Plasmodium vivax malaria, as well as from
...
